PSX
34
4
RIG
60
5
URBN
55
12
GOOG
55
-4
IVZ
48
-4
AAL
48
6
SBUX
36
-3
XRAY
34
11
EXR
48
2
GS
52
-7
XOM
42
5
HCA
50
2
CNP
44
8
ABBV
57
-2
MNST
65
5
GWW
64
-3
DG
29
2
OMC
59
4
KEY
33
-4
AA
43
2
PSX
34
4
RIG
60
5
URBN
55
12
GOOG
55
-4
IVZ
48
-4
AAL
48
6
SBUX
36
-3
XRAY
34
11
EXR
48
2
GS
52
-7
XOM
42
5
HCA
50
2
CNP
44
8
ABBV
57
-2
MNST
65
5
GWW
64
-3
DG
29
2
OMC
59
4
KEY
33
-4
AA
43
2
Financhill
Back

Haemonetics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
51

HAE
Haemonetics

Last Price:
73.54
Seasonality Move:
3.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Haemonetics Price Quote

$73.54
+0.01 (+2.88%)
(Updated: November 5, 2024 at 4:18 AM ET)

Haemonetics Key Stats

Buy
51
Haemonetics (HAE) is a Buy
Day range:
$71.43 - $73.67
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
32.11
P/S ratio:
2.84
P/B ratio:
4.16%
Volume:
607.9K
Avg. volume:
525.4K
1-year change:
-16.85%
Market cap:
$3.8B
Revenue:
$1.3B
EPS:
$2.23

How Much Does Haemonetics Make?

  • How Much Are Haemonetics's Sales Annually?
    HAE Revenues are $1.3B
  • How Much Profit Does Haemonetics's Make A Year?
    HAE net income is $117.6M

Is Haemonetics Growing As A Company?

  • What Is Haemonetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Haemonetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.08%

Haemonetics Stock Price Performance

  • Did Haemonetics Stock Go Up Last Month?
    Haemonetics share price went down by -5.6% last month
  • Did HAE's Share Price Rise Over The Last Year?
    HAE share price fell by -16.85% over the past 1 year

What Is Haemonetics 52-Week High & Low?

  • What Is Haemonetics’s 52-Week High Share Price?
    Haemonetics has traded as high as $97.97 over the past 52 weeks
  • What Is Haemonetics’s 52-Week Low Share Price?
    Haemonetics has traded as low as $70.25 over the past 52 weeks

Haemonetics Price To Free Cash Flow

Is It Risky To Buy Haemonetics?

  • How Much Debt Does Haemonetics Have?
    Total long term debt quarterly is $1.2B
  • How Much Cash Does Haemonetics Have?
    Cash and short term investments quarterly total is $344.4M
  • What Is Haemonetics’s Book Value Per Share?
    Book value per share is 17.70

Is Haemonetics Cash Flow Positive?

  • What Is HAE Cash Flow From Operations?
    Cash flow from operations (TTM) is $135.2M
  • What Is Haemonetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $372.4M
  • What Is Haemonetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$446.3M

Haemonetics Return On Invested Capital

  • Is Management Doing A Good Job?
    HAE return on invested capital is 6.39%
  • What Is Haemonetics Return On Assets?
    ROA measures how assets are converting to revenues and is 5.27%
  • What Is HAE Return On Equity?
    ROE is a measure of profitability and is 12.58%

Haemonetics Earnings Date & Stock Price

  • What Is Haemonetics's Stock Price Today?
    A single share of HAE can be purchased today for 73.53
  • What Is Haemonetics’s Stock Symbol?
    Haemonetics trades on the nyse under the ticker symbol: HAE
  • When Is Haemonetics’s Next Earnings Date?
    The next quarterly earnings date for Haemonetics is scheduled on November 7, 2024
  • When Is HAE's next ex-dividend date?
    Haemonetics's next ex-dividend date is November 5, 2024
  • How To Buy Haemonetics Stock?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Haemonetics Competitors

  • Who Are Haemonetics's Competitors?
    Below is a list of companies who compete with Haemonetics or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Cerus Corp (CERS)
    • Insulet Corp (PODD)
    • Teleflex Inc (TFX)

Haemonetics Dividend Yield

Haemonetics Analyst Estimates

YoY Growth Past Surprise
EPS: -7.5% 1.44%
Revenue: 7.98% 0.34%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 109.80
Upside from Last Price: 49.33%

Major Shareholders

  • How many HAE shares are owned by institutional investors?
    93.1M HAE shares are owned by institutional investors
  • How many HAE shares are owned by insiders?
    1.4M HAE shares are owned by insiders